Assessment cardioprotective activity of new preparation «Phepolenum» on alcohol-furasolidonum cardiomyopathia model

  • O.Ya. Mishchenko -
  • L.V. Yakovleva -
Keywords: experimental cardiomyopathia, combined preparation «Phepolenum», cardioprotective activity, eleuterococ extractum

Abstract

Cardioprotective activity of new combined preparation «Phepolenum», it is developed on the basis of beekeeping products and phenolic hydrophobic substance of propolis was established on alcohol-furasolidonum cardiomyopathia model in rats. It is established, cardioprotective activity of «Phepolenum» is conditioned by ability expresse oppressing influence on processes of lipids peroxidation and in-crease activi­ty of antioxidative organ’s system, normalize blood level of lipids, promoted regeneration proteinsynthetic processes. Phepolenum has cardioprotective activity as classic adaptogen — eleuterococ extractum.



References

Harutyunyan AV Dubinina EE Zybina NN // Methods for assessing free radical oxidation and antioxidant system of the body: Method. recommendations. - 2000. - SPb: IKF «Foliant» SPb. - 104 p.

Voronina LM, Desenko VF, Kravchenko VM etc. Handbook for laboratory and seminar classes in biological chemistry: Textbook. method. manual for universities. - X .: Основа, 1996. - 432 с.

Ivakhnenko AK, Bunyatyan ND, Yakovleva LV // Optimization of drug creation. Proceedings of the scientific-practical seminar on the development of new drugs. - X., 1999. - P. 98-105.

Lapach SN, Chubenko AV, Babich PN Statistical methods in biomedical research using Excel. - 2001. - 320 p.

Mishchenko O.Ya., Yakovleva LV // Medical chemistry. - 2004. - T. 6, № 4 - S. 28—32.

Prokhorova MI, Tupikova ZN Large workshop on carbohydrate and lipid metabolism. - L .: Lenkigr Publishing House. University, 1995. - P. 53—65.

Yakovleva LV, Kotelevets NV // Med. chemistry. - 2006. - T. 8, № 1. —С. 11 - 14.

Bagchi K., Puri S. // Eastern Mediterranean Health Journal. - 1998. - Vol. 4, № 2. - P. 350-360.

Das S., Nesaretnam K., Das D.K. // Vitam Horm. - 2007. - № 76. - P. 419—433.

Gatsura VV, Smirnov LD // Pharmaceutical chemistry J. - 1993. - Vol. 26, № 11—12. - P. 795—802.

Harman D. // Annals of the New York Academy of Sciences. - 1992. - Vol. 673. - P. 126-141.

Keaney J.F.Jr., Boston M.A. Oxidative Stress and Vascular Disease. - Kluwer Academic, 2000. - P. 195-211.

Lockwood S.F., Gross G.J. // Cardiovasc. Drug Rev. - 2005. - Vol. 23, № 3. - P. 199-216.

Pauly D.F., Pepine C.J. // Clin. Cardiol. - 2004. - Vol. 27, № 4. - P. 439-441.

Ren J., Brown R.A. // Alcohol and Alcoholism. - 2000. - Vol. 35, № 6. - P. 554-560.

Wu.J.M., Wang Z.R., Hsieh T.C. at al. // Int. J. Mol. Med. - 2001. - Vol. 8, № 1. - P. 3-17.

Published
2008-12-23
How to Cite
Mishchenko, O., & Yakovleva, L. (2008). Assessment cardioprotective activity of new preparation «Phepolenum» on alcohol-furasolidonum cardiomyopathia model. Farmatsevtychnyi Zhurnal, (6), 94-99. Retrieved from https://pharmj.org.ua/index.php/journal/article/view/1083
Section
Original Articles